Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Schmidt

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|November 10, 2010
Third-generation SERMs may face uphill battleCharlie Schmidt
Journal of the National Cancer Institute|October 23, 2010
The cancer-HIV/AIDS treatment conundrumCharlie Schmidt
Journal of the National Cancer Institute|March 26, 2011
Can some DCIS patients avoid adjuvant therapy? Still unknownCharlie Schmidt
Journal of the National Cancer Institute|November 6, 2015
Targeted Therapy Makes Inroads in MedulloblastomaCharlie Schmidt
Journal of the National Cancer Institute|December 10, 2013
Honing the health message on BRCA mutationsCharlie Schmidt
Journal of the National Cancer Institute|June 8, 2012
Cutaneous T-cell lymphoma's confounding natureCharlie Schmidt
Nature Biotechnology|August 11, 2006
Belated approval of first recombinant protein from animalCharlie Schmidt
Nature Biotechnology|August 11, 2006
Profile: Una RyanCharlie Schmidt
Nature Biotechnology|March 10, 2006
Toll-like receptor therapies compete to reduce side effectsCharlie Schmidt
Journal of the National Cancer Institute|August 2, 2013
Cancer research: evaluating the sequester's impactCharlie Schmidt
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|November 10, 2010
Third-generation SERMs may face uphill battleCharlie Schmidt
Journal of the National Cancer Institute|October 23, 2010
The cancer-HIV/AIDS treatment conundrumCharlie Schmidt
Journal of the National Cancer Institute|March 26, 2011
Can some DCIS patients avoid adjuvant therapy? Still unknownCharlie Schmidt
Journal of the National Cancer Institute|November 6, 2015
Targeted Therapy Makes Inroads in MedulloblastomaCharlie Schmidt
Journal of the National Cancer Institute|December 10, 2013
Honing the health message on BRCA mutationsCharlie Schmidt
Journal of the National Cancer Institute|June 8, 2012
Cutaneous T-cell lymphoma's confounding natureCharlie Schmidt
Nature Biotechnology|August 11, 2006
Belated approval of first recombinant protein from animalCharlie Schmidt
Nature Biotechnology|August 11, 2006
Profile: Una RyanCharlie Schmidt
Nature Biotechnology|March 10, 2006
Toll-like receptor therapies compete to reduce side effectsCharlie Schmidt
Journal of the National Cancer Institute|August 2, 2013
Cancer research: evaluating the sequester's impactCharlie Schmidt
Pageof 12